(GS71) GSK - Performance -6.4% in 12m
Compare GS71 with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
15.25%
#48 in Group
Rel. Strength
36.48%
#5070 in Universe
Total Return 12m
-6.35%
#83 in Group
Total Return 5y
17.59%
#56 in Group
P/E 22.4
57th Percentile in Group
P/E Forward 8.26
19th Percentile in Group
PEG 0.36
27th Percentile in Group
FCF Yield 5.22%
64th Percentile in Group
12m Total Return: GS71 (-6.4%) vs XLV (1.7%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: GS71 vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for GS71
Total Return (including Dividends) | GS71 | XLV | S&P 500 |
---|---|---|---|
1 Month | -0.34% | -3.79% | -0.87% |
3 Months | 4.85% | -3.99% | -7.58% |
12 Months | -6.35% | 1.72% | 11.88% |
5 Years | 17.59% | 55.40% | 110.33% |
Trend Score (consistency of price movement) | GS71 | XLV | S&P 500 |
1 Month | -8.30% | -3.2% | 23% |
3 Months | -30.1% | -71.4% | -88.5% |
12 Months | -56.8% | -17.5% | 55.1% |
5 Years | 67.5% | 89.8% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #94 | 3.59% | 0.53% |
3 Month | #40 | 9.21% | 13.5% |
12 Month | #83 | -7.93% | -16.3% |
5 Years | #58 | -24.3% | -44.1% |
FAQs
Does GS71 GSK outperforms the market?
No,
over the last 12 months GS71 made -6.35%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months GS71 made 4.85%, while XLV made -3.99%.
Over the last 3 months GS71 made 4.85%, while XLV made -3.99%.
Performance Comparison GS71 vs Indeces and Sectors
GS71 vs. Indices GS71 is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 4.82% | 0.53% | 8.82% | -18.2% |
US NASDAQ 100 | QQQ | 3.79% | -1.74% | 8.39% | -19.0% |
US Dow Jones Industrial 30 | DIA | 5.76% | 2.84% | 8.91% | -15.6% |
German DAX 40 | DAX | 6.05% | -1.66% | -10.7% | -31.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | 8.78% | 2.48% | 11.8% | -12.3% |
Hongkong Hang Seng | HSI | 5.81% | -0.40% | 6.90% | -20.2% |
India NIFTY 50 | INDA | 7.66% | -4.40% | 8.53% | -9.42% |
Brasil Bovespa | EWZ | 5.62% | -4.94% | 5.12% | -0.53% |
GS71 vs. Sectors GS71 is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.57% | 0.71% | 2.69% | -30.3% |
Consumer Discretionary | XLY | 4.74% | -0.24% | 6.31% | -19.7% |
Consumer Staples | XLP | 8.32% | -0.54% | 3.51% | -17.6% |
Energy | XLE | 9.30% | 13.5% | 14.6% | 4.74% |
Financial | XLF | 6.21% | 1.77% | 1.22% | -29.0% |
Health Care | XLV | 4.90% | 3.45% | 10.5% | -8.07% |
Industrial | XLI | 4.40% | -0.45% | 8.11% | -15.9% |
Materials | XLB | 5.43% | 2.09% | 16.2% | -2.83% |
Real Estate | XLRE | 6.34% | 0.97% | 9.71% | -24.4% |
Technology | XLK | 2.37% | -2.03% | 12.2% | -14.1% |
Utilities | XLU | 7.66% | -0.40% | 6.70% | -28.2% |
Aerospace & Defense | XAR | 3.87% | -6.73% | -4.71% | -32.9% |
Biotech | XBI | 3.52% | -2.62% | 21.5% | -4.52% |
Homebuilder | XHB | 5.51% | 1.93% | 23.6% | 0.68% |
Retail | XRT | 6.39% | 0.22% | 14.4% | -3.61% |